API Manufacture

MolecuNav’s fluorination technology offers clear advantages for the manufacture of fluorine-containing active pharmaceutical ingredients (APIs). Traditional methods often require multiple protecting group steps and harsh conditions, leading to lengthy, expensive, and environmentally taxing synthetic routes. Our chemistry eliminates these inefficiencies by enabling direct, selective fluorine incorporation—reducing step count, cost, and complexity.

This streamlined approach supports greater scalability, batch-to-batch consistency, and regulatory robustness, all critical for commercial manufacturing. Moreover, the ability to install fluorine at late stages in the synthesis opens opportunities for parallel analog generation, accelerating process optimization and route selection during development.

For manufacturers working with ¹⁹F-containing small molecules, MolecuNav provides a cleaner, faster, and more adaptable solution that integrates seamlessly into both early-phase scale-up and full GMP production.